Answers are grounded in this paper and cite their sources.
This paper discusses the definition of iron replete status in patients with heart failure and reduced ejection fraction receiving intravenous iron therapy.
Iron deficiency is an important therapeutic target in patients with heart failure and reduced ejection fraction (HFrEF). Over the past two decades, several trials of intravenous (IV) iron supplementation in HFrEF have shown favorable effects on symptoms, functional status, and heart failure (HF) hospitalizations...
No takes yet. Share an insight, caveat, or question.
Talha et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: